The Importance of the New Peptides As of 2021, five AOMs have been authorized for long-term administration in the United States: Previously utilized AOMs such as orlistat, phentermine/topiramate, naltrexone/bupropion generally resulted in 3%7% greater weight loss than placebo
The effect typically begins within 4560 minutes after administration and may last for several hours
The cost difference is minimal compared to wasted time and money on inactive products
Any visible particulate matter disqualifies the medication from use
Maribo, Heidi Solvang Nielsen, Maria Bjerremann Rasmussen, and Frank Strauss
These ligands include the endogenous substrate Tf and several different antibodies and peptides that bind to different epitopes of the receptor with Tf as the most extensively studied ligand for TfR-directed brain targeting [20]